Cite
MLA Citation
L Domínguez Casas et al.. “OP0059 Golimumab versus tocilizumab for severe and refractory juvenile idiopathic arthritis-uveitis. multicenter study of 33 patients.” Annals of the rheumatic diseases, vol. 76, n.d., pp. 75–76. http://access.bl.uk/ark:/81055/vdc_100135153748.0x000060